Sign In

Ryan Fukushima

Chief Operating Officer at Tempus | CEO at Pathos

Ryan Fukushima has played a pivotal role in developing Tempus with a focus on innovation, collaboration, and data-driven insights in the realm of precision medicine in healthcare.

Under Ryan's leadership, Tempus has amassed a substantial multimodal dataset in oncology, partnering with medical professionals and researchers to enhance treatment outcomes.

With a wealth of over 100PB of data, Tempus is at the forefront of leveraging AI to derive crucial insights that advance patient care and drive the field of precision medicine forward.

Ryan Fukushima's contributions have garnered recognition, including a placement in Endpoints News' prestigious list of top 20 leaders under 40 in biopharma and biotech in 2023.

Ryan has a solid educational background with an MBA in Business from the University of Michigan and a Bachelor of Science in Engineering from California Polytechnic State University-San Luis Obispo.

His professional experience includes leadership roles at Pathos, Tempus, Inc., Lightbank, and Hyde Park Venture Partners, where he honed his skills and expertise in the realms of entrepreneurship, operations, and venture capital.

Highlights

Tempus buys Mpirik to expand cardio capabilities - Crain's Chicago Business
Tempus buys Mpirik to expand cardio capabilities - Crain's Chicago Business
Eric Lefkofsky, Ryan Fukushima behind drug startup Pathos AI - Crain's Chicago Business
Eric Lefkofsky, Ryan Fukushima behind drug startup Pathos AI - Crain's Chicago Business
Ryan Fukushima
Add to my network

Location

Greater Chicago Area